𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a

✍ Scribed by Tichelli, A. ;Gratwohl, A. ;Berger, C. ;Lori, A. ;W�rsch, A. ;Dieterle, A. ;Thomssen, C. ;Nissen, C. ;Holdener, E. ;Speck, B.

Publisher
Springer-Verlag
Year
1989
Weight
449 KB
Volume
58
Category
Article
ISSN
1432-0584

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-alfa corrects thrombocytosis
Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders
✍ Heinz Ludwig; Werner Linkesch; Heinz Gisslinger; Elke Fritz; Helmut Sinzinger; T 📂 Article 📅 1987 🏛 Springer-Verlag 🌐 English ⚖ 835 KB

During previous therapeutic trials with interferon, decreased levels of peripheral platelet counts have been observed. Taking advantage of this effect, we investigated the efficacy of recombinant interferon (rec-IFN) in the treatment of thrombocytosis in myeloproliferative diseases. A total of 15 pa

ChemInform Abstract: The Role of Interfe
ChemInform Abstract: The Role of Interferon-Alpha in the Treatment of Myeloproliferative Disorders
✍ Claudia Fiorani; Stefania Tonelli; Barbara Casolari; Stefano Sacchi 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

Role of interferon alpha-2a in the treat
Role of interferon alpha-2a in the treatment of polycythemia vera
✍ Paolo Foa; Paolo Massaro; Sonia Ribera; Alessandra Lurlo; Carmen Mezzanotte; Dan 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB 👁 2 views

We studied the effects of recombinant interferon alpha-2a (IFN-alpha) in 36 patients with polycythemia Vera (PV) previously treated with phlebotomy and/or conventional cytostatic agents. In each patient, after at least 2 months of discontinuation of any cytotoxic therapy, the hematocrit (Hmt) was fi